Wu Jasmanda H, Fung Man C, Chan Wenyaw, Lairson David R
University of Texas-Houston School of Public Health, Houston, TX, USA.
Value Health. 2004 Mar-Apr;7(2):175-85. doi: 10.1111/j.1524-4733.2004.72326.x.
Tailored telephone counseling and physician-based and clinic-based interventions have been shown to be cost-effective in enhancing utilization of mammography among nonadherent women. The objective of this study was to evaluate the costs and benefits of a broad implementation of these interventions from a health payer perspective.
CAN*TROL computer modeling was employed in the cost-effectiveness analysis of interventions in a 2000 Texas female population. The estimated effects of the various interventions and their related costs derived from the literature were applied to a hypothetical scenario of a broad implementation of these interventions.
Seven studies were identified from the literature, six of them employed tailored telephone counseling (TC), whereas two used comprehensive physician-based (PB) or clinic-based (CB) interventions. The estimated intervention cost per women was 43 dollars for TC, 71 dollars for PB, and 151 dollars for CB. CAN*TROL model showed that after 15 years of implementation, TC, PB, and CB could reduce cancer mortality by 6.5, 2.2, and 10.7%, respectively. The cumulative net costs of interventions, mammography screening, and medical care costs were lower for TC (TC vs. PB vs. CB, 1.05 million vs. 1.06 million vs. 1.60 million). Nevertheless, CB resulted in more life-years saved (TC vs. PB vs. CB, 11,413 vs. 8515 vs. 14,559). The incremental cost-effectiveness ratio was more favorable for tailored telephone counseling interventions. One-way sensitivity analysis indicated that compliance rates and intervention costs had the most significant impact on the incremental cost-effectiveness ratio.
Tailored telephone counseling interventions may be the preferred first-line intervention for getting nonadherent women aged 50 to 79 years on schedule for mammography screening.
定制化电话咨询以及基于医生和诊所的干预措施已被证明在提高非依从性女性乳腺钼靶检查利用率方面具有成本效益。本研究的目的是从医疗支付方的角度评估广泛实施这些干预措施的成本和效益。
在对2000名得克萨斯州女性人群的干预措施进行成本效益分析时,采用了CAN*TROL计算机建模。从文献中得出的各种干预措施的估计效果及其相关成本被应用于这些干预措施广泛实施的假设情景。
从文献中确定了7项研究,其中6项采用了定制化电话咨询(TC),而2项采用了全面的基于医生(PB)或基于诊所(CB)的干预措施。每项女性的估计干预成本,TC为43美元,PB为71美元,CB为151美元。CAN*TROL模型显示,实施15年后,TC、PB和CB分别可将癌症死亡率降低6.5%、2.2%和10.7%。TC的干预措施、乳腺钼靶筛查和医疗护理成本的累计净成本较低(TC与PB与CB相比,分别为105万美元、106万美元和160万美元)。然而,CB节省的生命年更多(TC与PB与CB相比分别为11413、8515和14559)。定制化电话咨询干预措施的增量成本效益比更有利。单向敏感性分析表明依从率和干预成本对增量成本效益比影响最大。
定制化电话咨询干预措施可能是使50至79岁非依从性女性按时进行乳腺钼靶筛查首选一线干预措施。